![]() |
市場調查報告書
商品編碼
2058900
生物基化學品和綠色化學品市場預測至2034年-按產品類型、原料、製造技術、應用、終端用戶產業和地區分類的全球分析Bio-Based Chemicals & Green Chemicals Market Forecasts to 2034 - Global Analysis By Product Type, Feedstock, Production Technology, Application, End-Use Industry, and By Geography |
||||||
根據 Stratistics MRC 的數據,預計到 2026 年,全球生物基化學品和綠色化學品市場規模將達到 1,027 億美元,並在預測期內以 12.2% 的複合年成長率成長,到 2034 年將達到 2,579 億美元。
生物基和綠色化學品由可再生生物來源資源(例如植物、農業殘餘物和有機廢棄物)生產,為傳統的石油化學產品提供了永續的替代方案。這些化學品涵蓋廣泛的產品,包括生質塑膠、生質燃料、生物溶劑以及用於包裝、汽車、紡織、製藥和農業等領域的生物化學中間體。在日益嚴格的環境法規、企業不斷加強的永續發展措施以及消費者對低碳足跡產品日益成長的偏好的推動下,綠色化學正逐漸成為全球向循環經濟轉型的重要基石。
對石油化學產品排放嚴格的環境法規
世界各國政府正對揮發性有機化合物、溫室氣體排放和不可生物分解廢棄物實施更嚴格的限制,這直接推動了生物基替代品的採用。歐盟的「綠色新政」以及北美和亞洲的類似法規對傳統化學品生產進行處罰,同時為可再生原料提供稅收優惠和補貼。這些監管壓力推高了石化產品的生產成本,並提高了綠色化學品的成本競爭力。包裝、汽車和建築等行業面臨監管合規期限,正在加速向生物基聚合物、潤滑劑和溶劑轉型,以避免處罰並在環境法規嚴格的地區維持市場進入。
與石油化學產品相比,生產成本較高
由於原料預處理成本高、轉化效率低、生產規模小等因素,生物基化學品的生產成本仍遠高於傳統的石油化學製程。發酵、酵素處理和催化重整等製程需要專門的基礎設施和能源投入,這在一定程度上抵消了其環境效益。如果沒有大量的碳排放稅和補貼,生物基產品在價格上難以與成熟的石油基替代品競爭,尤其是在利潤微薄的通用化學品市場。這種成本壁壘限制了生物基產品的應用範圍,使其僅限於高階市場和具有環保意識的行業,從而阻礙了其在價格敏感型應用領域和開發中國家的廣泛普及。
合成生物學和代謝工程的進展
微生物基因工程的突破性進展使得利用簡單的醣類和廢棄物直接生產複雜化學品成為可能,且產量空前高昂。基因改造細菌和酵母現在可以合成可直接取代石油化學基礎原料(如琥珀酸、丁二醇和異戊二烯)的產品,從而省去了多個製作流程。這些創新同時降低了生產成本、能源消耗和廢棄物產生。此外,合成生物學平台能夠快速客製化微生物以適應特定的原料,包括混合農業殘渣和有機廢棄物,從而克服了傳統原料多樣性帶來的限制,並擴大了市場上經濟可行的生物基化學品的範圍。
生質能原料供應和價格的波動
氣候變遷、與糧食生產爭奪土地以及極端天氣事件造成的干擾,都為生物基化學品生產商帶來了農業市場的不確定性。乾旱、洪水或蟲害爆發可能導致玉米、甘蔗和植物油供應驟減,推高價格,直接影響生產的經濟效益。此外,政策轉向優先發展生質燃料而非生物化學品,可能會使原料從工業應用領域轉移出去。與依賴穩定原油品質的石油化工煉廠不同,生物煉廠必須應對生質能品質的季節性和地理波動,這需要昂貴的儲存和預處理系統,從而增加了營運的複雜性和財務風險。
新冠疫情初期透過供應鏈中斷和工業活動減少對生物基化學品市場造成了衝擊,但隨後卻加速了某些產業的需求。封鎖措施增加了食品配送和電子商務中可生物分解包裝的使用,而衛生意識的提高也推動了對生物基抗菌劑和清潔劑的需求。石化燃料市場的動盪暫時提升了生物基替代品的相對經濟可行性。然而,工業投資的推遲和新興技術研發資金的削減導致了長期的挫折。疫情最終凸顯了建立本地生物煉製廠和多元化供應鏈的必要性,促使企業調整長期策略,轉向更具韌性和可再生的化學品生產。
在預測期內,植物油和植物脂肪細分市場預計將佔據最大的市場佔有率。
由於其完善的加工基礎設施和廣泛的化學應用,預計植物油和植物脂肪領域將在預測期內佔據最大的市場佔有率。棕櫚油、大豆油、菜籽油和蓖麻油是生物溶劑、生物潤滑劑、界面活性劑和聚合物的直接原料,其現有的供應鏈已融入全球農業系統。這些油脂的碳鏈長度適合進行化學改性,並且已大規模生產用於食品和燃料行業,使其在可再生原料中具有成本競爭力。其廣泛的供應和成熟的轉化技術(包括酯交換和環氧化反應)預計將使其在整個預測期內繼續保持其在生物基化學品市場的主導地位。
在預測期內,合成生物學和代謝工程領域預計將呈現最高的複合年成長率。
在預測期內,合成生物學和代謝工程領域預計將呈現最高的成長率,這反映了為高價值化學品設計客製化生產途徑的巨大潛力。與依賴天然菌株的傳統發酵不同,基因改造微生物可以直接利用單醣和廢棄物生產特殊分子、藥物和新型聚合物。這項技術減少了合成步驟,最大限度地降低了產品分解,並實現了以前無法從生物來源原料中獲得的化學品的生產。創業投資對合成生物學新創企業的投資正在激增,香料、香精、單體和藥物活性成分等領域的商業化進程也在快速推進。隨著透過菌株的迭代最佳化降低生產成本,該領域的市場佔有率將不斷擴大。
在整個預測期內,北美預計將保持最大的市場佔有率,這得益於其豐富的農業原料、先進的生物煉製基礎設施以及可再生燃料標準(RFS)和類似項目的強力政策支持。美國在生物基聚合物、生物表面活性劑和工業酵素的商業化生產方面處於主導地位,各大化學企業都在大力投資,以實現產品組合多元化,拓展至可再生資源領域。加拿大豐富的林業殘餘物為其自身的木質纖維素轉化設施提供了支持。成熟的玉米、大豆和菜籽供應鏈確保了可靠的原料供應。再加上美國農業部(USDA)和能源部(DOE)提供的有利研究經費,北美在綠色化學創新和生產能力方面均保持主導地位。
在預測期內,亞太地區預計將呈現最高的複合年成長率,這主要得益於快速的工業化進程、不斷成長的化學品需求以及各國政府對可再生原料含量的積極監管。中國已將生物基化學品列為戰略性新興產業,並正在建造利用農業殘餘物和澱粉作物的大規模生物煉製廠。在印度,由於中產階級的壯大和污染問題的日益嚴重,生物分解性塑膠和生物溶劑的應用正在不斷成長。東南亞國家正在充分利用其豐富的棕櫚油和椰子油原料,而日本和韓國則在高附加價值生物基特種化學品領域處於領先地位。隨著歐美綠色化學法規對出口市場的影響,亞太地區的製造商正迅速轉向生物基原料,以保持其全球競爭力。
According to Stratistics MRC, the Global Bio based Chemicals Green Chemicals Market is accounted for $102.7 billion in 2026 and is expected to reach $257.9 billion by 2034 growing at a CAGR of 12.2% during the forecast period. Bio-based and green chemicals are derived from renewable biological sources such as plants, agricultural residues, and organic waste, offering sustainable alternatives to conventional petrochemicals. These chemicals encompass a wide range of products including bioplastics, biofuels, biosolvents, and biochemical intermediates used across packaging, automotive, textiles, pharmaceuticals, and agriculture. The market is propelled by tightening environmental regulations, corporate sustainability commitments, and growing consumer preference for products with lower carbon footprints, positioning green chemistry as a cornerstone of the global circular economy transition.
Stringent environmental regulations on petrochemical emissions
Governments worldwide are imposing stricter limits on volatile organic compounds, greenhouse gas emissions, and non-biodegradable waste, directly favoring bio-based alternatives. The European Union's Green Deal and similar mandates in North America and Asia penalize conventional chemical production while offering tax incentives and subsidies for renewable feedstocks. These regulatory pressures make petrochemicals increasingly expensive to produce, improving the cost competitiveness of green chemicals. Industries such as packaging, automotive, and construction face compliance deadlines, accelerating their shift toward bio-based polymers, lubricants, and solvents to avoid penalties and maintain market access in environmentally regulated jurisdictions.
High production costs compared to petrochemicals
Bio-based chemical manufacturing remains significantly more expensive than conventional petrochemical routes due to costly feedstock preprocessing, lower conversion efficiencies, and smaller production scales. Fermentation, enzymatic processing, and catalytic upgrading require specialized infrastructure and energy inputs that offset some environmental advantages. Without substantial carbon taxes or subsidies, bio-based products struggle to compete on price with mature petroleum-derived alternatives, particularly in commodity chemical markets where margins are razor-thin. This cost barrier limits adoption to premium market segments and environmentally conscious industries, preventing broader penetration across price-sensitive applications and developing economies.
Advances in synthetic biology and metabolic engineering
Breakthroughs in genetic modification of microorganisms are enabling direct production of complex chemicals from simple sugars and waste streams at unprecedented yields. Engineered bacteria and yeasts can now synthesize drop-in replacements for petrochemical building blocks such as succinic acid, butanediol, and isoprene, eliminating multiple processing steps. These innovations reduce production costs, energy consumption, and waste generation simultaneously. Synthetic biology platforms also allow rapid customization of microorganisms for specific feedstocks, including mixed agricultural residues and organic waste, overcoming previous limitations related to feedstock variability and expanding the range of economically viable bio-based chemicals entering the market.
Volatility in biomass feedstock supply and prices
Agricultural commodity markets face disruption from climate change, competing land use for food production, and extreme weather events, creating uncertainty for bio-based chemical manufacturers. Droughts, floods, or pest outbreaks can suddenly reduce availability of corn, sugarcane, and vegetable oils while driving prices upward, directly impacting production economics. Furthermore, policy shifts favoring biofuels over biochemicals can redirect feedstocks away from industrial applications. Unlike petrochemical refineries that rely on consistent crude oil grades, biorefineries must navigate seasonal and geographical variations in biomass quality, requiring expensive storage and pretreatment systems that add operational complexity and financial risk.
The COVID-19 pandemic initially disrupted bio-based chemical markets through supply chain halts and reduced industrial activity, but subsequently accelerated demand in specific segments. Lockdowns increased use of biodegradable packaging for food delivery and e-commerce, while heightened hygiene awareness drove demand for bio-based antimicrobials and cleaning agents. Disruptions in fossil fuel markets temporarily improved the relative economics of bio-based alternatives. However, postponed industrial investments and reduced R&D funding for emerging technologies created lasting setbacks. The pandemic ultimately reinforced the case for localized biorefineries and diversified supply chains, reshaping long-term strategies toward resilient, renewable chemical production.
The Vegetable Oils and Plant Oils segment is expected to be the largest during the forecast period
The Vegetable Oils and Plant Oils segment is expected to account for the largest market share during the forecast period, owing to their established processing infrastructure and versatile chemical applications. Palm, soybean, rapeseed, and castor oils serve as direct feedstocks for biosolvents, biolubricants, surfactants, and polymers, with existing supply chains integrated into global agriculture. These oils offer favorable carbon chain lengths for chemical modification and are already produced at massive scales for food and fuel industries, making them cost-competitive among renewable feedstocks. Their widespread availability and mature conversion technologies, including transesterification and epoxidation, ensure continued dominance in the bio-based chemicals landscape throughout the forecast timeline.
The Synthetic Biology and Metabolic Engineering segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the Synthetic Biology and Metabolic Engineering segment is predicted to witness the highest growth rate, reflecting transformative potential in designing customized production pathways for high-value chemicals. Unlike traditional fermentation relying on naturally occurring strains, engineered microorganisms can produce specialty molecules, pharmaceuticals, and novel polymers directly from simple sugars or waste streams. This technology reduces the number of synthesis steps, minimizes byproducts, and enables production of chemicals previously impossible to obtain from biological sources. Venture capital investment in synthetic biology startups has surged, driving rapid commercialization across flavors, fragrances, monomers, and active pharmaceutical ingredients. As production costs decline through iterative strain optimization, this segment will capture increasing market share.
During the forecast period, the North America region is expected to hold the largest market share, underpinned by abundant agricultural feedstocks, advanced biorefinery infrastructure, and strong policy support from the Renewable Fuel Standard and similar programs. The United States leads in commercial-scale production of bio-based polymers, biosurfactants, and industrial enzymes, with major chemical companies investing heavily in renewable portfolio diversification. Canada's vast forestry residues support unique lignocellulosic conversion facilities. Established supply chains for corn, soybean, and canola provide reliable feedstock access. Combined with favorable research funding from the USDA and DOE, North America maintains its leadership position in both innovation and production capacity for green chemicals.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, driven by rapid industrialization, rising chemical demand, and aggressive government mandates for renewable content. China has designated bio-based chemicals as a strategic emerging industry, building large-scale biorefineries using agricultural residues and starch crops. India's growing middle class and pollution crises are pushing adoption of biodegradable plastics and bio-solvents. Southeast Asian nations benefit from abundant palm and coconut oil feedstocks, while Japan and South Korea lead in high-value bio-based specialty chemicals. As Western green chemistry regulations impact export markets, Asia Pacific's manufacturers are rapidly transitioning to bio-based feedstocks to maintain global competitiveness.
Key players in the market
Some of the key players in Bio based Chemicals Green Chemicals Market include BASF SE, TotalEnergies SE, Archer Daniels Midland Company, DuPont de Nemours Inc, Evonik Industries AG, Toray Industries Inc, Cargill Incorporated, GFBiochemicals Ltd, Mitsubishi Chemical Group Corporation, Novonesis AS, Braskem SA, LyondellBasell Industries NV, PTT Global Chemical Public Company Limited, Eastman Chemical Company, Solvay SA, Dow Inc, Covestro AG, Neste Oyj and DSM Firmenich AG.
In April 2026, Mitsubishi Chemical announced the expansion of its Bio-Polycarbonate (DURABIO(TM)) production to meet soaring demand in the automotive and electronics sectors, where the plant-derived material is replacing traditional petroleum-based plastics.
In March 2026, LyondellBasell finalized a strategic move to secure more bio-based feedstocks for its CirculenRenew polymers, aiming to produce and market at least 2 million metric tons of recycled and renewable-based polymers annually by 2030.
In January 2026, At Pharmapack 2026, Braskem unveiled a new bio-based Low-Density Polyethylene (LDPE) grade (Medcol VV7040) specifically for the healthcare sector. The material boasts a negative carbon footprint of -2.27 kgCO2e/kg.
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.